H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 11 010 KRW 0.82% Market Closed
Market Cap: 190.5B KRW
Have any thoughts about
Hana Pharm Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is 18 097.78 KRW. Compared to the current market price of 11 010 KRW, Hana Pharm Co Ltd is Undervalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
18 097.78 KRW
Undervaluation 39%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hana Pharm Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Hana Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Hana Pharm Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

11 010 KRW
+0.82%
+0.82%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Hana Pharm Co Ltd
KR
Pharmaceuticals
Market Cap
190.5B KRW
IPO
Oct 2, 2018
Employees
657
Korea
Market Cap
190.5B KRW
Industry
Pharmaceuticals
IPO
Oct 2, 2018
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hana Pharm Co Ltd

Provide an overview of the primary business activities
of Hana Pharm Co Ltd.

What unique competitive advantages
does Hana Pharm Co Ltd hold over its rivals?

What risks and challenges
does Hana Pharm Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hana Pharm Co Ltd.

Provide P/S
for Hana Pharm Co Ltd.

Provide P/E
for Hana Pharm Co Ltd.

Provide P/OCF
for Hana Pharm Co Ltd.

Provide P/FCFE
for Hana Pharm Co Ltd.

Provide P/B
for Hana Pharm Co Ltd.

Provide EV/S
for Hana Pharm Co Ltd.

Provide EV/GP
for Hana Pharm Co Ltd.

Provide EV/EBITDA
for Hana Pharm Co Ltd.

Provide EV/EBIT
for Hana Pharm Co Ltd.

Provide EV/OCF
for Hana Pharm Co Ltd.

Provide EV/FCFF
for Hana Pharm Co Ltd.

Provide EV/IC
for Hana Pharm Co Ltd.

Show me price targets
for Hana Pharm Co Ltd made by professional analysts.

What are the Revenue projections
for Hana Pharm Co Ltd?

How accurate were the past Revenue estimates
for Hana Pharm Co Ltd?

What are the Net Income projections
for Hana Pharm Co Ltd?

How accurate were the past Net Income estimates
for Hana Pharm Co Ltd?

What are the EPS projections
for Hana Pharm Co Ltd?

How accurate were the past EPS estimates
for Hana Pharm Co Ltd?

What are the EBIT projections
for Hana Pharm Co Ltd?

How accurate were the past EBIT estimates
for Hana Pharm Co Ltd?

Compare the revenue forecasts
for Hana Pharm Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hana Pharm Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hana Pharm Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hana Pharm Co Ltd compared to its peers.

Compare the P/E ratios
of Hana Pharm Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hana Pharm Co Ltd with its peers.

Analyze the financial leverage
of Hana Pharm Co Ltd compared to its main competitors.

Show all profitability ratios
for Hana Pharm Co Ltd.

Provide ROE
for Hana Pharm Co Ltd.

Provide ROA
for Hana Pharm Co Ltd.

Provide ROIC
for Hana Pharm Co Ltd.

Provide ROCE
for Hana Pharm Co Ltd.

Provide Gross Margin
for Hana Pharm Co Ltd.

Provide Operating Margin
for Hana Pharm Co Ltd.

Provide Net Margin
for Hana Pharm Co Ltd.

Provide FCF Margin
for Hana Pharm Co Ltd.

Show all solvency ratios
for Hana Pharm Co Ltd.

Provide D/E Ratio
for Hana Pharm Co Ltd.

Provide D/A Ratio
for Hana Pharm Co Ltd.

Provide Interest Coverage Ratio
for Hana Pharm Co Ltd.

Provide Altman Z-Score Ratio
for Hana Pharm Co Ltd.

Provide Quick Ratio
for Hana Pharm Co Ltd.

Provide Current Ratio
for Hana Pharm Co Ltd.

Provide Cash Ratio
for Hana Pharm Co Ltd.

What is the historical Revenue growth
over the last 5 years for Hana Pharm Co Ltd?

What is the historical Net Income growth
over the last 5 years for Hana Pharm Co Ltd?

What is the current Free Cash Flow
of Hana Pharm Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hana Pharm Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hana Pharm Co Ltd

Current Assets 100.8B
Cash & Short-Term Investments 5.2B
Receivables 43B
Other Current Assets 52.7B
Non-Current Assets 250.2B
Long-Term Investments 69.8B
PP&E 158.6B
Intangibles 15.5B
Other Non-Current Assets 6.4B
Current Liabilities 32.3B
Accounts Payable 5.5B
Accrued Liabilities 3B
Short-Term Debt 2B
Other Current Liabilities 21.9B
Non-Current Liabilities 37.7B
Long-Term Debt 24.9B
Other Non-Current Liabilities 12.8B
Efficiency

Earnings Waterfall
Hana Pharm Co Ltd

Revenue
225.2B KRW
Cost of Revenue
-86.7B KRW
Gross Profit
138.5B KRW
Operating Expenses
-116.5B KRW
Operating Income
22.1B KRW
Other Expenses
-2.5B KRW
Net Income
19.5B KRW

Free Cash Flow Analysis
Hana Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hana Pharm Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
53/100
Profitability
Score

Hana Pharm Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hana Pharm Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Low D/E
Short-Term Solvency
79/100
Solvency
Score

Hana Pharm Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hana Pharm Co Ltd

Wall Street analysts forecast Hana Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hana Pharm Co Ltd is 18 360 KRW with a low forecast of 18 180 KRW and a high forecast of 18 900 KRW.

Lowest
Price Target
18 180 KRW
65% Upside
Average
Price Target
18 360 KRW
67% Upside
Highest
Price Target
18 900 KRW
72% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hana Pharm Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hana Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Hana Pharm Co Ltd stock?

The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is 18 097.78 KRW.

Is Hana Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 11 010 KRW, Hana Pharm Co Ltd is Undervalued by 39%.

Back to Top